Impact of trade margin cap on anti-cancer medicines clarified by NPPA

The National Pharmaceutical Pricing Authority (NPPA) has issued consumer FAQs explaining its trade margin cap on 137 specified non-scheduled anti-cancer medicines, effective 9 November 2026. The measure seeks to curb excessive supply-chain mark-ups and improve affordability. The cap does not mean every medicine will become 30% cheaper; actual price reductions will vary by formulation.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.